中国组织工程研究 ›› 2013, Vol. 17 ›› Issue (37): 6645-6651.doi: 10.3969/j.issn.2095-4344.2013.37.017

• 组织构建基础实验 basic experiments in tissue construction • 上一篇    下一篇

Myod1和Myog真核共表达载体构建及鉴定

高宏飞,梁炳生,双卫兵   

  1. 山西医科大学外科学教研室,山西省太原市  030001
  • 收稿日期:2013-06-04 修回日期:2013-07-17 出版日期:2013-09-10 发布日期:2013-09-10
  • 通讯作者: 梁炳生,博士,教授,博士生导师,山西医科大学,山西省太原市 030001 doctordr2008@sina.cn
  • 作者简介:高宏飞☆,男,1975年生,山西省代县人,汉族, 2013年山西医科大学毕业,博士,主要从事外科学的分子生物学研究。 ghf0036@sina.com
  • 基金资助:

    国家自然科学基金面上项目(81000805)*

Construction and identification of eukaryotic co-expression vector carrying Myod1 and Myog

Gao Hong-fei, Liang Bing-sheng, Shuang Wei-bing   

  1. Department of Surgery, Shanxi Medical University, Taiyuan  030001, Shanxi Province China
  • Received:2013-06-04 Revised:2013-07-17 Online:2013-09-10 Published:2013-09-10
  • Contact: Liang Bing-sheng, M.D., Professor, Doctoral supervisor, Department of Surgery, Shanxi Medical University, Taiyuan 030001, Shanxi Province China doctordr2008@sina.cn
  • About author:Gao Hong-fei☆, M.D., Department of Surgery, Shanxi Medical University, Taiyuan 030001, Shanxi Province China ghf0036@sina.com
  • Supported by:

    General Project of National Natural Science Foundation of China, No. 81000805*

摘要:

背景:目前研究发现,生肌调节因子家族的各成员之间具有相互协同和相互促进的作用。因此,联合应用Myod1和Myog两个成员进行基因治疗,可能会取得更好的疗效,能够为防治失神经支配骨骼肌萎缩寻找新的思路。
目的:构建Myod1和Myog基因的真核共表达载体。
方法:通过RT-PCR的方法克隆大鼠Myod1和Myog基因的全长cDNA,酶切后依次插入到pVAX1载体中,以构建重组的Myod1和Myog真核共表达载体pVAX1-Myod1-IRES2-Myog-IRES2-EGFP,采用基因测序的方法进行鉴定。将pVAX1-Myod1-IRES2-Myog-IRES2-EGFP对体外培养的3T3细胞进行转染,利用Western blot检测3T3细胞中Myod1蛋白和Myog蛋白的表达,验证其能否正确表达目的蛋白。
结果与结论:基因测序结果表明,真核共表达载体pVAX1-Myod1-IRES2-Myog-IRES2-EGFP内的Myod1和Myog cDNA的序列长度及碱基顺序均与所公布的序列相同。将该载体转染到体外培养的3T3细胞内,Western blot能够检测到3T3细胞中Myod1和Myog蛋白的条带。结果证实,实验成功构建了重组Myod1和Myog真核共表达载体pVAX1-Myod1-IRES2-Myog-IRES2-EGFP。

关键词: 组织构建, 组织构建基础实验, Myod1, Myog, 真核共表达载体, 基因转染, 基因测序, 失神经支配, 骨骼肌萎缩, 国家自然科学基金

Abstract:

BACKGROUND: Now it has cooperation and facilitative effete between myogenic regulatory factors through a long time study. So, gene therapy of double genes of Myod1 and Myog can obtain better effect, and can provide a new way for preventing denervated skeletal muscle atrophy.
OBJECTIVE: To construct eukaryotic co-expression vector carrying Myod1 and Myog genes.
METHODS: Full-length Myod1 gene and Myog gene cDNA were amplified by reverse transcription PCR, and then inserted into pVAX1 vector after digested to establish the recombined Myod1 and Myog eukaryotic co-expression vector pVAX1-Myod1-IRES2-Myog-IRES2-EGFP, and then identified with gene sequencing. The in vitro cultured 3T3 cells were transfected with pVAX1-Myod1-IRES2-Myog-IRES2-EGFP, and the expressions of Myod1 and Myog genes in the 3T3 cells were detected with western blot assay in order to identify whether the 3T3 cells could express the target protein correctly.
RESULTS AND CONCLUSION: The sequencing results showed that the sequence length and base sequence of Myod1 and Myog cDNA in eukaryotic co-expression vector pVAX1-Myod1-IRES2-Myog-IRES2-EGFP were identical with the reported sequences. Myod1 and Myog protein band expressions were detected in 3T3 cells by western blot after transient transfection. The pVAX1-Myod1-IRES2-Myog-IRES2-EGFP, a eukaryotic co-expression vector of Myod1 gene and Myog gene is successfully constructed.

Key words: animals, genetically modified, myofibrils, atrophy, muscle, skeletal, denervation

中图分类号: